Musgrave B L, Phu T, Butler J J, Makrigiannis A P, Hoskin D W
Department of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, B3H 4H7, Canada.
Exp Cell Res. 1999 Oct 10;252(1):96-103. doi: 10.1006/excr.1999.4631.
TRAIL (TNF-related apoptosis inducing ligand), like other members of the TNF family of proteins, is able to induce apoptosis in sensitive target cells. Recently, cell-surface TRAIL has been shown to be expressed by activated human and mouse T lymphocytes, raising the possibility that TRAIL might be involved in T cell-mediated cytotoxicity and/or immune regulation. In the present study we show by semiquantitative reverse transcriptase polymerase chain reaction (RT-PCR) analysis that activated, but not resting, mouse T cells express abundant TRAIL mRNA. TRAIL transcripts were detectable within 4 h of T cell activation. A panel of pharmacologic inhibitors was used to investigate the signal transduction pathways involved in TRAIL gene induction following T lymphocyte activation. TRAIL gene expression was sensitive to the src-like protein tyrosine kinase (PTK) inhibitor herbimycin A, as well as the more general PTK inhibitor genistein, suggesting the involvement of a src family PTK. The PKC inhibitors staurosporine and calphostin C, and the phosphatidylinositol 3-kinase (PI3-K) inhibitors wortmannin and LY294002, also prevented TRAIL mRNA transcription by activated T cells, indicating a role for PKC and PI3-K. In addition, TRAIL induction was inhibited by cyclosporin A, implicating the Ca(2+)/calmodulin-dependent protein phosphatase calcineurin. TRAIL expression was also blocked by rapamycin, which inhibits p70 S6 kinase involved in CD28 and interleukin (IL)-2 receptor signaling. However, TRAIL mRNA expression was not induced by IL-2, suggesting that TRAIL gene induction is not coupled to the IL-2 receptor. Data obtained by RT-PCR were confirmed at the protein level by immunoblotting with TRAIL-specific antibody. We conclude that TRAIL gene induction is initiated through a T cell receptor-associated signaling pathway similar to that responsible for the expression of cytokine genes such as IL-2.
肿瘤坏死因子相关凋亡诱导配体(TRAIL)与肿瘤坏死因子(TNF)家族的其他蛋白质成员一样,能够在敏感靶细胞中诱导凋亡。最近研究表明,活化的人和小鼠T淋巴细胞可表达细胞表面TRAIL,这提示TRAIL可能参与T细胞介导的细胞毒性作用和/或免疫调节。在本研究中,我们通过半定量逆转录酶聚合酶链反应(RT-PCR)分析发现,活化而非静息的小鼠T细胞表达大量TRAIL mRNA。在T细胞活化后4小时内即可检测到TRAIL转录本。我们使用一组药理抑制剂来研究T淋巴细胞活化后参与TRAIL基因诱导的信号转导途径。TRAIL基因表达对src样蛋白酪氨酸激酶(PTK)抑制剂赫曲霉素A以及更通用的PTK抑制剂染料木黄酮敏感,这表明src家族PTK参与其中。蛋白激酶C(PKC)抑制剂星形孢菌素和钙泊三醇,以及磷脂酰肌醇3激酶(PI3-K)抑制剂渥曼青霉素和LY294002,也可阻止活化T细胞的TRAIL mRNA转录,这表明PKC和PI3-K发挥了作用。此外,环孢菌素A可抑制TRAIL的诱导,这表明钙调神经磷酸酶(一种依赖于Ca²⁺/钙调蛋白的蛋白磷酸酶)参与其中。雷帕霉素也可阻断TRAIL的表达,雷帕霉素可抑制参与CD28和白细胞介素(IL)-2受体信号传导的p70 S6激酶。然而,IL-2不能诱导TRAIL mRNA表达,这表明TRAIL基因诱导与IL-2受体无关。通过用TRAIL特异性抗体进行免疫印迹在蛋白质水平证实了RT-PCR获得的数据。我们得出结论,TRAIL基因诱导是通过与T细胞受体相关的信号转导途径启动的,该途径类似于负责细胞因子基因(如IL-2)表达的信号转导途径。